Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 5Terminated 2Unknown 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 10Rectal Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Stomach Neoplasms 4Thyroid Neoplasms 2Oropharyngeal Neoplasms 2NSCLC 2Lung Neoplasms 2Head and Neck Neoplasms 2Glioblastoma 2Colorectal Neoplasms 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Turcot syndrome 1Triple Negative Breast Neoplasms 1Thymic epithelial tumor 1Spinal Metastasis 1Sarcoma 1Resectable Non-small Cell Lung Cancer 1Recurrence 1Prostatic Neoplasms 1Pilonidal Sinus 1Pathologic Complete Response 1Pancoast Syndrome 1Pain, Postoperative 1Pain 1Ovarian Neoplasms 1Mouth Neoplasms 1Microsatellite Instability 1

Interventions

Paclitaxel 2liposomal doxorubicin 1irinotecan sucrosofate 1fluzoparib 1envafolimab 1apatinib 1anlotinib 1Topotecan 1Surgical Procedures, Operative 1Neoadjuvant Therapy 1Losartan 1Indocyanine Green 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Carcinoma, Ovarian Epithelial × Surgical Procedures, Operative × Clear all
NCT06602063 2025-06-27

Surgery for Relapsed Ovarian Cancer in Precision

Shanghai Gynecologic Oncology Group

Phase 1/2 Not yet recruiting
33 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡